NEW DELHI (AP) — The world’s largest vaccine maker, based in India, will be able to restart exports of AstraZeneca doses by June if new coronavirus infections subside in the country, its chief executive said Tuesday.
Six months after being diagnosed with Covid-19, 1 in 3 patients also had experienced a psychiatric or neurological illness, mostly mood disorders but also strokes or dementia, a large new study shows.
Last Saturday, the U.S. hit a new high for the number of daily vaccinations: 4 million. The record day came as vaccinations have steadily risen over recent weeks, bringing the daily average to more than 3 million.
Nearly half of new coronavirus infections nationwide are in just five states — a situation that is putting pressure on the federal government to consider changing how it distributes vaccines by sending more doses to hot spots.
Recent Comments